Biological E plans to make 1.5 billion Corbevax jabs in 2021

By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.The vaccine, named PTX-COVID19-B, is under development in Canada and......

Kolkata group against GSK's AIDS patent

Drug major GlaxoSmithKline's plan to patent its HIV/AIDS drug - Combivir - in India may hit a roadblock as a Kolkata-based NGO, Manipur Network of People Living with HIV/AIDS, has filed a pre-grant......

GSK relaunches Horlicks

Glaxo SmithKline on Tuesday re-launched its flagship brand Horlicks. Horlicks will now be positioned as a pleasurable nourishment drink aimed at children between the age group of 8 -14.Addressing a......

Govt clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

The government on Thursday cleared Rs 6,400-crore (Rs 64-billion) FDI proposal of global healthcare company GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm. The Cabinet......

Malaria drug: Glenmark settles dispute with GSK

Glenmark Pharmaceuticals said on Monday its US-based group company has settled a patent dispute with GlaxoSmithKline over the launch of a generic version of anti-malaria drug Malarone. Glenmark......